Trxade Group Inc (MEDS) — Cash Flow Reinvestment Rate
Trxade Group Inc (MEDS) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting $774.00 (capex $0.00 plus investments $-774.00) from operating cash flow of $4.22 Million. Explore Trxade Group Inc (MEDS) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Trxade Group Inc Cash Flow Reinvestment Rate (2017–2019)
Historical reinvestment intensity for Trxade Group Inc across 3 annual periods. See Trxade Group Inc (MEDS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Annual Cash Flow Reinvestment Rate for Trxade Group Inc (2017–2019)
Year-by-year capital reinvestment analysis for Trxade Group Inc. For the full cash flow conversion analysis, see Trxade Group Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 2.92x | $414.50K | $141.78K | $82.25K | ▲ +185.2% |
| 2018 | 1.03x | $280.29K | $273.39K | $15.01K | ▼ -33.6% |
| 2017 | 1.54x | $265.01K | $171.67K | $15.01K | — |